LENZ Therapeutics (LENZ) Return on Assets (2021 - 2026)
LENZ Therapeutics (LENZ) posted quarterly Return on Assets of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 17.47% quarter-over-quarter from 0.0% in Q4 2025.
LENZ Therapeutics (LENZ) Return on Assets (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Return on Assets for 6 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets eased to 0.0% in Q1 2026 per LENZ's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q4 2024 and bottomed at 0.02% in Q1 2023.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.0% in 2024.
- Annual changes were most pronounced in 2022 — Return on Assets declined 2 bps — and 2023, when it rose 2 bps.
- LENZ Therapeutics' Return on Assets stood at 0.02% in 2022, then surged by 63 bps to 0.01% in 2023, then surged by 73 bps to 0.0% in 2024, then plunged by 44 bps to 0.0% in 2025, then dropped by 17 bps to 0.0% in 2026.
- Business Quant data shows LENZ's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 0.00% |
| 10 | LENZ Therapeutics | 149.66 Mn | 149.66 Mn | 5.21 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |